The unique plasma assets serve as the foundation of the Chronos-PD program, driving advanced research at Grifols subsidiary Alkahest, which is leading the initiative given its specialization in the ...

Spanish drugmaker Grifols has been awarded a $21 million grant from the Michael J Fox Foundation to support a pilot study to ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

"Grifols developed its new fibrinogen to be more convenient, faster to prepare and storable at room temperature, an advantage over alternatives such as cryoprecipitate or fresh frozen plasma when ...

The Catalan blood products company has received a $21 million grant from the Michael J. Fox Foundation (MJFF) for Parkinson's ...

Will fund a pilot study to analyze longitudinal plasma samples covering a period of up to 10 years.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Character Abbotsford's next big event is the Character in Action Awards on May 8, 2025. The venue is still be determined, but ...

A new analysis of data from the PHENIX experiment at the Relativistic Heavy Ion Collider (RHIC) reveals fresh evidence that ...

NEW ORLEANS — In the days after the terrorist attack, there was an outpouring of support at The Blood Center. Half of the many who donated were either new donors or donors returning for the first time ...